+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Therapeutic Plasma Exchange Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Pre Book Price: $ 5216

Original Price: $ 5795

Therapeutic plasma exchange is the group of procedures to separate the plasma from blood components for the purpose of removing defective cells or depleting disease mediators. An apheresis procedure effectively removes pathogenic substances in blood that contributes to disease state. Therapeutic plasma exchange involves plamapheresis and cytapheresis. Plasmapheresis is removal or exchange of blood plasma and cytapheresis is group of procedures for blood cell removal or exchange. The objective of the therapy of plasmapheresis therapy is to remove antibodies or suspected antibodies responsible in the pathogenesis of autoimmune disease. The procedure is used mainly in renal and metabolic diseases, hematologic and neurologic disorders. 

The conventional apheresis methods include two technologies such as centrifugation and membrane filtration for the removal of pathogen from plasma. The most common use of therapeutic plasma exchange is for the treatment of autoimmune disease. These procedures are now performed by fully automated machines to separate the pathogen by disposable extracorporeal blood pathways with safe and efficient methods. The plasma which is removed can be replaced either by fresh frozen plasma, similar colloidal solutions or the patient’s own plasma after secondary purification procedures.

The growing prevalence of neurological, inflammatory diseases and increasing clinical response rate for therapeutic plasma exchange are driving the growth of market. Over the last few years the therapeutic plasma exchange has witnessed the stable growth in market due to changing lifestyle pattern, increasing innovative technologies for the therapy, and growing awareness among physicians. However the factors such as high cost therapies because of advanced machineries, lack of awareness about the process in developing countries and risk associated with the procedures may restrain the market growth.

The segmentation of the therapeutic plasma exchange market can be done on the basis of indications, end-users and geography. The procedure is used in various indications such as neurological disorders, autoimmune disorders, hematology disorders, metabolic disorders, and renal disorders. Autoimmune diseases is the widest category in which the procedure is used. Hematology disorders include thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, cryoglobulinemia, multiple myeloma. The neurological disorder is further sub segmented in diseases such as chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, multiple sclerosis, neuromylitis optica, Guillain–Barré syndrome (GBS), while renal disorders include post renal transplant rejection, Anti-GBM Disease (Goodpasture Syndrome), Wegner’s granulomatosis (ANCA-associated rapidly progressive glomerulonephritis metabolic disorders familial hypercholesterolemia. The increasing prevalence of diseases, geriatric population necessitating the need for therapeutic plasma exchange worldwide and subsequent increase in incident and prevalence of chronic life style diseases are increasing the demand for therapeutic plasma exchange for the treatment of diseases  are propelling the growth of market. The increasing use of the therapeutic plasma exchange procedures in rare and hematological diseases is also expected to boost the number of procedures.

Hospitals, research laboratories, and ambulatory surgery centers form the major end-users of the market. The procedure is mostly carried out at multi-specialty hospitals. Geographically, the therapeutic plasma exchange procedure market is segmented in North America, Europe, Asia pacific, Latin America and the Middle East and Africa.

The major players in the therapeutic plasma exchange market are Fresenius SE & Co. KGaA, B. Braun Melsungen AG, Baxter International, Inc., Asahi Kasei Medical Co., Ltd., Terumo BCT, Inc., Haemonetics Corporation, Kawasumi Laboratories, Inc., and Hemacare Corporation.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape. 

The study is a source of reliable data on:

  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs 

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, North Africa) 

TMR estimates the market size of various sectors using a combination of available data on the number and revenue of companies within each sub-sector and tiers of companies. The basic components used to determine market size and forecast for a specific product area are not only limited to supply-side data, but are also related to demand, industry trends, and the economic outlook. All the above data points are utilized to generate a statistical model targeting the sector marketplace. More than 300 TMR analysts across the world integrate these elements into a framework to determine the subsector market size for a base year and then forecast growth within each market. 

TMR regularly interviews technology and business professionals as an ongoing effort to track the latest developments within each sector. These continuous surveys are stratified by company size and industry segment and weighted to reflect the global market place.  All data are collected on an ongoing effort through a structured questionnaire rolled over the web or conducted via telephones. This provides the TMR team opportunities to request for detailed question sets, complex skip patterns, and real-time calculations, which assists respondents in answering questions involving numbers and percentages. Respondents, who are interviewed as experts, are screened and qualified based on certain criteria in addition to their decision-making authority and the scope of activity within their organizations.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.

To receive discount, please click on the button below.

Please click on the button below to customize this report.

Back To Top